9 Results

People

  1. Ponomarev
    Ponomarev
  2. Tap
    Tap
  3. Choi
    Choi
  4. Fanchon
    Fanchon
  5. Grkovski
    Grkovski
  6. Hellmann
    Hellmann
  7. Humm
    Humm
  8. Lowery
    Lowery
  9. Merghoub
    Merghoub
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (5)
  2. Solid Tumor Oncology Division (5)
  3. Radiochemistry and Imaging Sciences Service (4)
  4. Radiology, Department of (4)
  5. Sarcoma Service (3)
  6. Sloan Kettering Institute Postdocs (3)
  7. Center for Pancreatic Cancer Research (1)
  8. Gastrointestinal Oncology Service (1)
  9. Medical Physics (1)
  10. Melanoma and Immunotherapeutics Service (1)
  1. "evofosfamide"
Formats
  1. Journal Article (9)
Groups
  1. Department of Medicine (5)
  2. Solid Tumor Oncology Division (5)
  3. Radiochemistry and Imaging Sciences Service (4)
  4. Radiology, Department of (4)
  5. Sarcoma Service (3)
  6. Sloan Kettering Institute Postdocs (3)

More Groups

People
  1. Vladimir Ponomarev (3)
  2. William Tap (3)
  3. Changhwan Yoon (1)
  4. Do Joong Park (1)
  5. Eileen O'Reilly (1)
  6. Hyejin Choi (1)

More People

Years
  1. 2025 (1)
  2. 2022 (1)
  3. 2020 (1)
  4. 2018 (1)
  5. 2017 (1)
  6. 2016 (1)

More Years

Publications
  1. Cancer Medicine (2)
  2. British Journal of Cancer (1)
  3. Cancer Letters (1)
  4. EJNMMI Research (1)
  5. Hematology/Oncology Clinics of North America (1)
  6. Journal of Experimental Medicine (1)

More Publications

Publishers
  1. Elsevier Inc. (2)
  2. Wiley Blackwell (2)
  3. Elsevier Ireland Ltd. (1)
  4. MDPI (1)
  5. Nature Publishing Group (1)
  6. Rockefeller University Press (1)

More Publishers

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer
    Journal Article

    Robles-Oteíza, C.; Hastings, K.; Choi, J.; Sirois, I.; Ravi, A.; Expósito, F.; de Miguel, F.; Knight, J. R.; López-Giráldez, F.; Choi, H.; more...
    Journal of Experimental Medicine (2025)

    Fulltext@MSK | Save
  • AI-Radiomics can improve inclusion criteria and clinical trial performance
    Journal Article

    Tomaszewski, M. R.; Fan, S.; Garcia, A.; Qi, J.; Kim, Y.; Gatenby, R. A.; Schabath, M. B.; Tap, W. D.; Reinke, D. K.; Makanji, R. J.; more...
    Tomography (2022)

    Fulltext@MSK | Save
  • Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial
    Journal Article

    Younger, E.; Ballman, K.; Lu, Y.; Pápai, Z.; Van Tine, B. A.; Attia, S.; Schöffski, P.; Reinke, D.; Tap, W. D.; Jones, R. L.
    Journal of Geriatric Oncology (2020)

    Fulltext@MSK | Save
  • (18)F-fluoromisonidazole predicts evofosfamide uptake in pancreatic tumor model
    Journal Article

    Grkovski, M.; Fanchon, L.; Pillarsetty, N. V. K.; Russell, J.; Humm, J. L.
    EJNMMI Research (2018)

    Fulltext@MSK | Save
  • Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma
    Journal Article

    Liapis, V.; Zysk, A.; DeNichilo, M.; Zinonos, I.; Hay, S.; Panagopoulos, V.; Shoubridge, A.; Difelice, C.; Ponomarev, V.; Ingman, W.; more...
    Cancer Medicine (2017)

    Fulltext@MSK | Save
  • Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models
    Journal Article

    Liapis, V.; Zinonos, I.; Labrinidis, A.; Hay, S.; Ponomarev, V.; Panagopoulos, V.; Zysk, A.; DeNichilo, M.; Ingman, W.; Atkins, G. J.; more...
    Cancer Medicine (2016)

    Fulltext@MSK | Save
  • Novel therapeutics for pancreatic adenocarcinoma
    Journal Article

    Lowery, M. A.; O'Reilly, E. M.
    Hematology/Oncology Clinics of North America (2015)

    Fulltext@MSK | Save
  • Hypoxia-activated chemotherapeutic TH-302 enhances the effects of VEGF-A inhibition and radiation on sarcomas
    Journal Article

    Yoon, C.; Lee, H. J.; Park, D. J.; Lee, Y. J.; Tap, W. D.; Eisinger-Mathason, T. S. K.; Hart, C. P.; Choy, E.; Simon, M. C.; Yoon, S. S.
    British Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma
    Journal Article

    Liapis, V.; Labrinidis, A.; Zinonos, I.; Hay, S.; Ponomarev, V.; Panagopoulos, V.; Denichilo, M.; Ingman, W.; Atkins, G. J.; Findlay, D. M.; more...
    Cancer Letters (2015)

    Fulltext@MSK | Save